
    
      For this clinical trial, there are two treatment groups, i.e., investigational patients who
      receive the MAVERICK™ Total Disc Replacement and control patients who receive the anterior
      lumbar interbody fusion procedure with INFUSE® Bone Graft/LT-CAGE® Lumbar Tapered Fusion
      Device. Each investigational site will enroll patients in a 2:1 investigational:control
      treatment randomization scheme.
    
  